Ivana Brkić Biloš

Ivana Brkić Biloš

Auto-generated profile, based on publicly available information

Ivana Brkić Biloš

Croatian Institute of Public Health, 10000 Zagreb, Croatia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2015 in Cardiologia Croatica
Verified
Journal Article
Closed access
VKVerica Kralj
Verica Kralj
IBIvana Brkic Bilos
Ivana Brkic Bilos
TCTanja Coric
Tanja Coric
MRMaja Silobrcic Radic
Maja Silobrcic Radic
MSMario Sekerija
Mario Sekerija

21 November 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
ŽRŽeljko Reiner
Željko Reiner
Bojan JelakovićBojan Jelaković
Bojan Jelaković
DMDavor Miličić
Davor Miličić
MBMarija Bubaš
Marija Bubaš
IBInes Balint
Ines Balint
IPIvan Pećin
Ivan Pećin
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide, including in Croatia. Since most patients have multiple disorders and diseases caused largely by the same risk factors, and as it is essential to approach each patient as a person with all disorders, today, we are talking about a new paradigm—cardio-renal-metabolic (CKM) syndrome and cardio-renal-metabolic health, which necessarily includes brain health. Elevated systolic blood pressure, LDL cholesterol, smoking, obesity, diabetes, impaired renal function or chronic kidney disease, which all stem from insufficient physical activity, an unhealthy diet with excessive intake of table salt, and air pollution, are the leading causes of overall morbidity and mortality from CKM diseases, especially mortality from CVD. Experts from various fields key to CKM health have written this document with the aim of integrating it as part of the national plan for the prevention of chronic non-communicable diseases with a focus on CVD, which should become mandatory and be based on the existing guidelines of professional societies.

1 November 2016 in Cardiologia Croatica
Verified
Journal Article
Closed access
VKVerica Kralj
Verica Kralj
IBIvana Brkić
Ivana Brkić
BIBiloš
Biloš

1 November 2018 in Cardiologia Croatica
Verified
Journal Article
Closed access
VKVerica Kralj
Verica Kralj
PČPetra Čukelj
Petra Čukelj
IBIvana Brkić Biloš
Ivana Brkić Biloš
KCKrunoslav Capak
Krunoslav Capak

31 December 2025 in Cancers
Verified
Journal Article
Open access
PDF file
ACAugust Cesarec
August Cesarec
NANataša Antoljak
Nataša Antoljak
IBIvana Brkić Biloš
Ivana Brkić Biloš
MŠMario Šekerija
Mario Šekerija
MVMaja Vajagić
Maja Vajagić
NLNEVEN LJUBIČIĆ
NEVEN LJUBIČIĆ
Background/Objectives: Colorectal cancer is the most frequently diagnosed cancer and second by mortality among all cancers in Croatia. The Organized National Colorectal Cancer Screening Program was introduced by the government in 2007. It targets individuals aged 50–74 years with a biennial screening with a guaiac fecal occult blood test (gFOBT). The aim of this study is to analyze the costs associated with colorectal cancer in Croatia and to compare the cost-effectiveness of three screening strategies: no screening, biennial gFOBT, and biennial fecal immunochemical testing (FIT). Patients and methods: A model was developed to compare the three screening scenarios. The model simulated a cohort of 10,000 patients aged 50 years without colorectal cancer. Health outcomes and associated costs were projected over a five-year time horizon. The model outcomes include the number of newly diagnosed colorectal cancer cases, number of colorectal cancer-related deaths, life-years gained, and costs per life-year gained. Results: The average five-year costs per patient for the treatment of advanced cancer are EUR 39,802, which is substantially higher than the average costs of EUR 16,897 per patient across all stages. The implemented model indicates that both screening options yielded improved health outcomes at lower costs compared with no screening. FIT is considered the preferred screening option due to its higher sensitivity, greater health outcomes, and lower costs relative to gFOBT. Conclusions: The introduction of FIT screening instead of gFOBT could increase screening uptake for colorectal cancer, improve health outcomes, and reduce healthcare expenditures and the economic burden associated with colorectal cancer in Croatia.

19 September 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
ŽRŽeljko Reiner
Željko Reiner
Bojan JelakovićBojan Jelaković
Bojan Jelaković
DMDavor Miličić
Davor Miličić
MBMarija Bubaš
Marija Bubaš
IBInes Balint
Ines Balint
IPIvan Pećin
Ivan Pećin
Cardiovascular diseases (CVD) are the leading cause of morbidity and mortality worldwide, including in Croatia. Since most patients have multiple disorders and diseases caused largely by the same risk factors, and as it is essential to approach each patient as a person with all disorders, today we are talking about a new paradigm - cardio-renal-metabolic (CKM) syndrome and cardio-renal-metabolic health, which necessarily includes brain health. Elevated systolic blood pressure, LDL cholesterol, smoking, obesity, diabetes, impaired renal function or chronic kidney disease, which all stem from insufficient physical activity, unhealthy diet with excessive intake of table salt, and air pollution, are the leading causes of overall morbidity and mortality from CKM diseases, especially mortality from CVD. Experts from various fields key to CKM health have written this document with the aim of integrating it as part of the national plan for the prevention of chronic non-communicable diseases with a focus on CVD, which should become mandatory and be based on the existing guidelines of professional societies.